1. Home
  2. HXHX vs ASBP Comparison

HXHX vs ASBP Comparison

Compare HXHX & ASBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HXHX

Haoxin Holdings Limited Class A Ordinary Shares

HOLD

Current Price

$0.53

Market Cap

16.8M

Sector

Industrials

ML Signal

HOLD

Logo Aspire Biopharma Holdings Inc.

ASBP

Aspire Biopharma Holdings Inc.

HOLD

Current Price

$0.10

Market Cap

18.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HXHX
ASBP
Founded
2003
2021
Country
China
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.8M
18.9M
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
HXHX
ASBP
Price
$0.53
$0.10
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
375.5K
67.6M
Earning Date
04-30-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.26
N/A
Revenue
$25,571,810.00
$1,941.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$2.01
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.48
$0.09
52 Week High
$6.29
$15.80

Technical Indicators

Market Signals
Indicator
HXHX
ASBP
Relative Strength Index (RSI) 36.39 29.17
Support Level $0.49 $0.10
Resistance Level $0.64 $0.11
Average True Range (ATR) 0.10 0.02
MACD 0.01 0.00
Stochastic Oscillator 10.67 19.29

Price Performance

Historical Comparison
HXHX
ASBP

About HXHX Haoxin Holdings Limited Class A Ordinary Shares

Haoxin Holdings Ltd is engaged in the logistics industry, including container provider of temperature-controlled truckload service and urban delivery services in China, freight forwarding, cold chain transportation and other businesses. The types of goods involved are all kinds of new energy materials that require low temperature, heat preservation, and constant temperature, electronic products, medicines, meat, fruits, vegetables and others.

About ASBP Aspire Biopharma Holdings Inc.

Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.

Share on Social Networks: